Management of thrombocytopenia due to liver cirrhosis: a review
about
The pathophysiology of thrombocytopenia in chronic liver diseaseEntecavir-Associated Thrombocytopenia in a Decompensated Cirrhotic Patient: A Case Report and Literature ReviewHemostasis in liver transplantation: Pathophysiology, monitoring, and treatmentBacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic DiseasesManagement before hepatectomy for hepatocellular carcinoma with cirrhosisCorrelation of platelets count with endoscopic findings in a cohort of Egyptian patients with liver cirrhosis.Serum thrombopoietin levels and its relationship with thrombocytopenia in patients with cirrhosis.A Model-Based Illustrative Exploratory Approach to Optimize the Dosing of Peg-IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple TherapyHelicobacter pylori infection influences the severity of thrombocytopenia and its treatment response in chronic hepatitis B patients with compensatory cirrhosis: A multicenter, observational study.Thrombocytopenia in chronic liver disease.Platelet Counts and Genetic Polymorphisms of Alcohol Dehydrogenase-1B and Aldehyde Dehydrogenase-2 in Japanese Alcoholic Men.Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.Predictive Factors in the Incidence of Cirrhosis in Chronic Hepatitis B Virus Infections.Cryptolepine, an indoloquinoline alkaloid, in the management of diabetes mellitus and its associated complicationsEthyl Acetate Fraction of Amomum xanthioides Exerts Antihepatofibrotic Actions via the Regulation of Fibrogenic Cytokines in a Dimethylnitrosamine-Induced Rat Model.How do we transfuse blood components in cirrhotic patients undergoing gastrointestinal procedures?Acquired amegakaryocytic thrombocytopenia previously diagnosed as idiopathic thrombocytopenic purpura in a patient with hepatitis C virus infectionImmature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study.Coagulation Management During Liver Transplantation: Use of Fibrinogen Concentrate, Recombinant Activated Factor VII, Prothrombin Complex Concentrate, and Antifibrinolytics.
P2860
Q26749277-0A20634C-66EA-47A0-A94F-E23D512D0AE9Q26750766-ACAFC6EB-C1FC-45F3-A0F4-35D62A9F3AB3Q26773233-13161DB8-7DB5-43AE-A5F9-6BF11A96FC4FQ26778773-66329D91-7633-4B18-98C3-BAE29BC716FAQ26783874-4C70A4BF-4C35-4DF1-B674-F21033487DC1Q30378111-3C01803C-E6F5-482A-98F0-2024408D80D3Q33416172-A04E18B6-ADC4-469F-B15E-24E15B201B67Q33424823-B14B984B-BD3B-4D50-AAD9-69B3AFA6D9ACQ33425621-332980B3-AB7D-47FD-803D-304FF80E8BABQ33436905-72099DB4-C7D5-450B-BD78-58291EC16124Q33437735-5F174674-7053-42FE-AC1F-C3BA7B6B43CAQ35594262-9C4EE97C-5E3D-4B44-9FE3-7A126783B581Q37017919-CA518BDF-BBDE-417A-A3DA-273B67192C59Q37052420-1CE2FBCE-8B85-4305-8F23-6F933C96E352Q37198484-4D94FF94-DEB3-4122-B177-7867741D1A0EQ39997164-DB1BB73D-C156-4BCC-A2EB-C275AE26E43BQ42695171-D5FEE079-E113-4688-838A-2E4C3FD8B74BQ50041720-2A8E64DC-8FFF-409D-93DC-4226D6BA8594Q52445950-3571884B-17B4-402F-BADF-F9997FA28E8D
P2860
Management of thrombocytopenia due to liver cirrhosis: a review
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Management of thrombocytopenia due to liver cirrhosis: a review
@ast
Management of thrombocytopenia due to liver cirrhosis: a review
@en
type
label
Management of thrombocytopenia due to liver cirrhosis: a review
@ast
Management of thrombocytopenia due to liver cirrhosis: a review
@en
prefLabel
Management of thrombocytopenia due to liver cirrhosis: a review
@ast
Management of thrombocytopenia due to liver cirrhosis: a review
@en
P2093
P2860
P356
P1476
Management of thrombocytopenia due to liver cirrhosis: a review
@en
P2093
Hideo Baba
Hiromitsu Hayashi
Ken Shirabe
Toru Beppu
P2860
P304
P356
10.3748/WJG.V20.I10.2595
P407
P577
2014-03-01T00:00:00Z